The prostate-localized kallikreins: Prostate specific antigen and human kallikrein 2

Mohammad S. Saedi, Harry G. Rittenhouse, Judith A. Finlay, Stephen D. Mikolajczyk, Alan Wayne Partin

Research output: Contribution to journalArticle

Abstract

Prostate specific antigen (PSA) and human kallikrein 2 (hK2) are closely related serine proteases localized primarily in the prostate gland. Despite the molecular similarities of the two prostate kallikreins, recent studies have revealed striking differences between hK2 and PSA. Unlike the weak chymotrypsin-like activity exhibited by PSA, hK2 is a potent trypsin-like enzyme with more than 20,000-fold relative higher enzyme activity than PSA on peptide substrates. The inactive precursor form of PSA, proPSA, is converted efficiently to active PSA by hK2 suggesting an important in vivo regulatory role for hK2 on PSA activity. The high homology between hK2 and PSA results in significant cross-reactivity to hK2 by polyclonal and some monoclonal antibodies to PSA. Monoclonal antibodies specific to hK2 with minimal cross- reactivity to PSA have been produced, allowing cell and serum analysis of hK2. Although the same secretory epithelial cells in the prostate produce both kallikreins, hK2 is more highly expressed in poorly differentiated cancer cells and is more tumor associated than PSA. Preliminary serum studies with immunoassays specific for hK2 indicate that serum hK2 in combination with total and free PSA provides increased specificity for prostate cancer.

Original languageEnglish (US)
Pages (from-to)371-375
Number of pages5
JournalJournal of Clinical Ligand Assay
Volume22
Issue number4
StatePublished - Dec 1999

Fingerprint

Tissue Kallikreins
Kallikreins
Prostate
Prostate-Specific Antigen
human kallikrein-related peptidase 3
Monoclonal Antibodies
Plasma Kallikrein
Chymotrypsin
Enzyme activity
Serine Proteases
Enzymes
Serum
Immunoassay
Trypsin
Tumors
Neoplasms
Prostatic Neoplasms

Keywords

  • HK2
  • Kallikreins
  • Prostate cancer
  • PSA

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology

Cite this

Saedi, M. S., Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., & Partin, A. W. (1999). The prostate-localized kallikreins: Prostate specific antigen and human kallikrein 2. Journal of Clinical Ligand Assay, 22(4), 371-375.

The prostate-localized kallikreins : Prostate specific antigen and human kallikrein 2. / Saedi, Mohammad S.; Rittenhouse, Harry G.; Finlay, Judith A.; Mikolajczyk, Stephen D.; Partin, Alan Wayne.

In: Journal of Clinical Ligand Assay, Vol. 22, No. 4, 12.1999, p. 371-375.

Research output: Contribution to journalArticle

Saedi, MS, Rittenhouse, HG, Finlay, JA, Mikolajczyk, SD & Partin, AW 1999, 'The prostate-localized kallikreins: Prostate specific antigen and human kallikrein 2', Journal of Clinical Ligand Assay, vol. 22, no. 4, pp. 371-375.
Saedi, Mohammad S. ; Rittenhouse, Harry G. ; Finlay, Judith A. ; Mikolajczyk, Stephen D. ; Partin, Alan Wayne. / The prostate-localized kallikreins : Prostate specific antigen and human kallikrein 2. In: Journal of Clinical Ligand Assay. 1999 ; Vol. 22, No. 4. pp. 371-375.
@article{8ea2b6b127954bdbad6c0c22d9def9f6,
title = "The prostate-localized kallikreins: Prostate specific antigen and human kallikrein 2",
abstract = "Prostate specific antigen (PSA) and human kallikrein 2 (hK2) are closely related serine proteases localized primarily in the prostate gland. Despite the molecular similarities of the two prostate kallikreins, recent studies have revealed striking differences between hK2 and PSA. Unlike the weak chymotrypsin-like activity exhibited by PSA, hK2 is a potent trypsin-like enzyme with more than 20,000-fold relative higher enzyme activity than PSA on peptide substrates. The inactive precursor form of PSA, proPSA, is converted efficiently to active PSA by hK2 suggesting an important in vivo regulatory role for hK2 on PSA activity. The high homology between hK2 and PSA results in significant cross-reactivity to hK2 by polyclonal and some monoclonal antibodies to PSA. Monoclonal antibodies specific to hK2 with minimal cross- reactivity to PSA have been produced, allowing cell and serum analysis of hK2. Although the same secretory epithelial cells in the prostate produce both kallikreins, hK2 is more highly expressed in poorly differentiated cancer cells and is more tumor associated than PSA. Preliminary serum studies with immunoassays specific for hK2 indicate that serum hK2 in combination with total and free PSA provides increased specificity for prostate cancer.",
keywords = "HK2, Kallikreins, Prostate cancer, PSA",
author = "Saedi, {Mohammad S.} and Rittenhouse, {Harry G.} and Finlay, {Judith A.} and Mikolajczyk, {Stephen D.} and Partin, {Alan Wayne}",
year = "1999",
month = "12",
language = "English (US)",
volume = "22",
pages = "371--375",
journal = "Journal of Clinical Ligand Assay",
issn = "1081-1672",
publisher = "Clinical Ligand Assay Society Inc.",
number = "4",

}

TY - JOUR

T1 - The prostate-localized kallikreins

T2 - Prostate specific antigen and human kallikrein 2

AU - Saedi, Mohammad S.

AU - Rittenhouse, Harry G.

AU - Finlay, Judith A.

AU - Mikolajczyk, Stephen D.

AU - Partin, Alan Wayne

PY - 1999/12

Y1 - 1999/12

N2 - Prostate specific antigen (PSA) and human kallikrein 2 (hK2) are closely related serine proteases localized primarily in the prostate gland. Despite the molecular similarities of the two prostate kallikreins, recent studies have revealed striking differences between hK2 and PSA. Unlike the weak chymotrypsin-like activity exhibited by PSA, hK2 is a potent trypsin-like enzyme with more than 20,000-fold relative higher enzyme activity than PSA on peptide substrates. The inactive precursor form of PSA, proPSA, is converted efficiently to active PSA by hK2 suggesting an important in vivo regulatory role for hK2 on PSA activity. The high homology between hK2 and PSA results in significant cross-reactivity to hK2 by polyclonal and some monoclonal antibodies to PSA. Monoclonal antibodies specific to hK2 with minimal cross- reactivity to PSA have been produced, allowing cell and serum analysis of hK2. Although the same secretory epithelial cells in the prostate produce both kallikreins, hK2 is more highly expressed in poorly differentiated cancer cells and is more tumor associated than PSA. Preliminary serum studies with immunoassays specific for hK2 indicate that serum hK2 in combination with total and free PSA provides increased specificity for prostate cancer.

AB - Prostate specific antigen (PSA) and human kallikrein 2 (hK2) are closely related serine proteases localized primarily in the prostate gland. Despite the molecular similarities of the two prostate kallikreins, recent studies have revealed striking differences between hK2 and PSA. Unlike the weak chymotrypsin-like activity exhibited by PSA, hK2 is a potent trypsin-like enzyme with more than 20,000-fold relative higher enzyme activity than PSA on peptide substrates. The inactive precursor form of PSA, proPSA, is converted efficiently to active PSA by hK2 suggesting an important in vivo regulatory role for hK2 on PSA activity. The high homology between hK2 and PSA results in significant cross-reactivity to hK2 by polyclonal and some monoclonal antibodies to PSA. Monoclonal antibodies specific to hK2 with minimal cross- reactivity to PSA have been produced, allowing cell and serum analysis of hK2. Although the same secretory epithelial cells in the prostate produce both kallikreins, hK2 is more highly expressed in poorly differentiated cancer cells and is more tumor associated than PSA. Preliminary serum studies with immunoassays specific for hK2 indicate that serum hK2 in combination with total and free PSA provides increased specificity for prostate cancer.

KW - HK2

KW - Kallikreins

KW - Prostate cancer

KW - PSA

UR - http://www.scopus.com/inward/record.url?scp=0033493062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033493062&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033493062

VL - 22

SP - 371

EP - 375

JO - Journal of Clinical Ligand Assay

JF - Journal of Clinical Ligand Assay

SN - 1081-1672

IS - 4

ER -